However, one report, in which ALK is driven in the mouse neural crest by either DBHiCre or TH-IRES-Cre, resulted in tumor development, highlighting the need to consider ALK expression levels carefully in a temporal and spatial context in neuroblastoma [59]. The gene discussed is ALK; the disease is neoplasm.